Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Favaretto

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Inorganic Chemistry|August 18, 2020
Expanding the Scope of Pyclen-Picolinate Lanthanide Chelates to Potential Theranostic ApplicationsGwladys Nizou, Chiara Favaretto, Francesca Borgna, et al.
Ecology and Evolution|April 27, 2026
Contrasting Reproductive and Early Life-History Strategies in Recently Diverged Octocoral Species (<i>Paramuricea</i> spp.)Christina Egger, Aschwin H Engelen, Roland R Melzer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 1, 2025
Preclinical investigation of [<sup>149</sup>Tb]Tb-DOTATATE and [<sup>149</sup>Tb]Tb-DOTA-LM3 for tumor-targeted alpha therapyAna Katrina Mapanao, Sarah D Busslinger, Avni Mehta, et al.
Neuroimage. Clinical|October 1, 2023
A common low dimensional structure of cognitive impairment in stroke and brain tumorsSilvia Facchini, Chiara Favaretto, Marco Castellaro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 11, 2025
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 StudyJulia G Fricke, Frida Westerbergh, Lisa McDougall, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Inorganic Chemistry|August 18, 2020
Expanding the Scope of Pyclen-Picolinate Lanthanide Chelates to Potential Theranostic ApplicationsGwladys Nizou, Chiara Favaretto, Francesca Borgna, et al.
Ecology and Evolution|April 27, 2026
Contrasting Reproductive and Early Life-History Strategies in Recently Diverged Octocoral Species (<i>Paramuricea</i> spp.)Christina Egger, Aschwin H Engelen, Roland R Melzer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 1, 2025
Preclinical investigation of [<sup>149</sup>Tb]Tb-DOTATATE and [<sup>149</sup>Tb]Tb-DOTA-LM3 for tumor-targeted alpha therapyAna Katrina Mapanao, Sarah D Busslinger, Avni Mehta, et al.
Neuroimage. Clinical|October 1, 2023
A common low dimensional structure of cognitive impairment in stroke and brain tumorsSilvia Facchini, Chiara Favaretto, Marco Castellaro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 11, 2025
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 StudyJulia G Fricke, Frida Westerbergh, Lisa McDougall, et al.
Pageof 3